MedPath

Advances in Screening and Prevention In REproductive Cancers (ASPIRE): A community based trial to determine optimal cervical cancer screening in a low-resource setting

Not Applicable
Completed
Conditions
Cervical Cancer
Cancer
Registration Number
ISRCTN04500116
Lead Sponsor
niversity of British Columbia (Canada)
Brief Summary

2015 preliminary results in: https://www.ncbi.nlm.nih.gov/pubmed/26031572 (added 12/04/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
600
Inclusion Criteria

1. Women aged 30-65
2. Live and or work in Kisenyi, Uganda
3. Access to mobile telephone
4. Fluent in Luganda, Somali or English
5. Competent to provide consent

Exclusion Criteria

1. Known to be pregnant by self-report at study entry
2. Complete hysterectomy
3. Prior diagnosis or treatment of cervical dysplasia or cervical cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath